Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group 2 Pulmonary Hypertension”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableActive Not RecruitingNCT06350773
What this trial is testing

Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension

Who this might be right for
Group 2 Pulmonary Hypertension
Beni-Suef University 48
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Testing effectiveness (Phase 2)Study completedNCT02279160
What this trial is testing

Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 61
Large-scale testing (Phase 3)Looking for participantsNCT05983250
What this trial is testing

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Who this might be right for
Pulmonary Hypertension
Tenax Therapeutics, Inc. 230
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)WithdrawnNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc
Testing effectiveness (Phase 2)WithdrawnNCT06643143
What this trial is testing

IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Inhibikase Therapeutics
Post-approval studies (Phase 4)Looking for participantsNCT07147114
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Who this might be right for
Combined Pre- and Post-capillary Pulmonary HypertensionCpcPHHFmrEF+2 more
Gachon University Gil Medical Center 64
Testing effectiveness (Phase 2)Ended earlyNCT02736149
What this trial is testing

Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 51
Testing effectiveness (Phase 2)Study completedNCT05737940
What this trial is testing

AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Who this might be right for
Pulmonary Hypertension (World Health Organization Group 2)Heart Failure
AstraZeneca 260
Testing effectiveness (Phase 2)Study completedNCT02664558
What this trial is testing

Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Who this might be right for
Pulmonary Arterial Hypertension
Eiger BioPharmaceuticals 61
Not applicableWithdrawnNCT05332873
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF Canada

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Testing effectiveness (Phase 2)Study completedNCT01728220
What this trial is testing

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Bellerophon Pulse Technologies 159
Not applicableWithdrawnNCT05205265
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Not applicableEnrolling By InvitationNCT06052072
What this trial is testing

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Who this might be right for
Group 2 Pulmonary HypertensionHeart Failure
Gradient Denervation Technologies 50
Testing effectiveness (Phase 2)Ended earlyNCT01725269
What this trial is testing

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 17
Early research (Phase 1)Study completedNCT02267655
What this trial is testing

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis
Bellerophon 8
Testing effectiveness (Phase 2)Ended earlyNCT03556020
What this trial is testing

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Who this might be right for
Pulmonary Arterial Hypertension
PhaseBio Pharmaceuticals Inc. 35
Not applicableStudy completedNCT05001711
What this trial is testing

Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
Aria CV, Inc 18
Load More Results